<DOC>
	<DOCNO>NCT02152696</DOCNO>
	<brief_summary>This randomize controlled trial compare three currently available management strategy woman persist pregnancy unknown location ( PPUL ) , make at-risk ectopic pregnancy . We recruit hemodynamically stable woman confirm PPUL randomize one three strategy : 1 ) Uterine evacuation follow methotrexate ( MTX ) ( evidence non visualize ectopic pregnancy ) 2 ) Empiric treatment MTX 3 ) Expectant management . Randomization 1:1:1 three arm . After randomization , follow treat clinically indicated progression condition . Primary outcome measure : uneventful decline hCG 5 IU/mL .</brief_summary>
	<brief_title>Optimal Treatment Women With Persisting Pregnancy Unknown Location</brief_title>
	<detailed_description />
	<mesh_term>Cardiac Complexes , Premature</mesh_term>
	<mesh_term>Pregnancy , Ectopic</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Female persist pregnancy unknown location : A pregnancy unknown location define pregnancy woman positive pregnancy test definitive sign pregnancy uterus adnexa ultrasound image . A definitive sign gestation include ultrasound visualization gestational sac yolk sac ( without embryo ) uterus adnexa . Ultrasound must perform within 7 day prior randomization . Persistence hCG define least 2 serial hCG value ( 214 day ) , show &lt; 15 % rise per day , &lt; 50 % fall first last value . Patient hemodynamically stable , hemoglobin &gt; 10 mg/dL Greater 18 year age Hemodynamically unstable need acute treatment Most recent hCG &gt; 5000 mIU/mL Patient obtain care relation recently complete pregnancy ( delivery , spontaneous elective abortion ) Diagnosis gestational trophoblastic disease Subject unwilling unable comply study procedure Presence clinical contraindication treatment MTX Prior medical surgical management gestation Subject unwilling accept blood transfusion</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>